Evidence map›Paper›PMID 39201720›Full record

ReviewInternational journal of molecular sciences2024

Wilson's Disease-Crossroads of Genetics, Inflammation and Immunity/Autoimmunity: Clinical and Molecular Issues.

Grażyna Gromadzka, Julia Czerwińska, Elżbieta Krzemińska, Adam Przybyłkowski, Tomasz Litwin

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. A novel homozygous variant in theFrontiers in medicine · 2026
    Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Cuproptosis and its potential role in musculoskeletal disease.Frontiers in cell and developmental biology · 2025
    Review
  15. Article
  16. Article
  17. Psychiatric Symptoms in Wilson's Disease-Consequence ofInternational journal of molecular sciences · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Grażyna GromadzkaDepartment of Biomedical Sciences, Faculty of Medicine, Collegium Medicum, Cardinal Stefan Wyszynski University, Wóycickiego Street 1/3, 01-938 Warsaw, Poland.ORCID 0000-0002-4325-8971
Julia CzerwińskaStudents Scientific Association "Immunis", Cardinal Stefan Wyszynski University, Dewajtis Street 5, 01-815 Warsaw, Poland.
Elżbieta KrzemińskaStudents Scientific Association "Immunis", Cardinal Stefan Wyszynski University, Dewajtis Street 5, 01-815 Warsaw, Poland.
Adam PrzybyłkowskiDepartment of Gastroenterology and Internal Medicine, Medical University of Warsaw, Banacha 1a, 02-097 Warsaw, Poland.ORCID 0000-0002-5851-2856
Tomasz LitwinSecond Department of Neurology, Institute of Psychiatry and Neurology, Sobieskiego Street 9, 02-957 Warsaw, Poland.ORCID 0000-0003-2670-9651

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Wilson's disease (WD) is a rare, autosomal recessive disorder of copper metabolism caused by pathogenic mutations in the

Indexed as

AutoimmunityHepatolenticular DegenerationInflammationAnimalsCopperCopper-Transporting ATPasesHumansMutationATP7B protein, humanCopperCopper-Transporting ATPasesATP7Bautoantibodiesautoimmunitycoppercuproptosisferroptosisimmunologyinflammationoxidative stressWilson’s disease

Identifiers

PMID39201720
PMCPMC11354778

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.